Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?

Jan M Friedman , Yvonne Bombard , Bruce Carleton , Amalia M Issa
Genetics in medicine 26 ( 2) 101033 -101033

2024
“Game changer”: health professionals’ views on the clinical utility of circulating tumor DNA testing in hereditary cancer syndrome management

Salma Shickh , Leslie E Oldfield , Marc Clausen , Chloe Mighton
The Oncologist 27 ( 5) e393 -e401

10
2022
Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy

Kirsten M Farncombe , Derek Wong , Maia L Norman , Leslie E Oldfield
The American Journal of Human Genetics 110 ( 10) 1616 -1627

2
2023
Genome Reporting for Healthy Populations—Pipeline for Genomic Screening from the GENCOV COVID‐19 Study

Erika Frangione , Monica Chung , Selina Casalino , Georgia MacDonald
Current Protocols 2 ( 10) e534 -e534

1
2022
“I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening

Ella Adi-Wauran , Marc Clausen , Salma Shickh , Anna R Gagliardi
European Journal of Human Genetics 32 ( 2) 176 -181

2024
Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol

Sebastian Lunke , Sophie E Bouffler , Lilian Downie , Jade Caruana
BMJ open 14 ( 4) e081426 -e081426

1
2024
The Genetic Discrimination Observatory: confronting novel issues in genetic discrimination

Yann Joly , Katherine Huerne , Mykhailo Arych , Yvonne Bombard
Trends in Genetics 37 ( 11) 951 -954

12
2021
955 Editing the plastid genome of recalcitrant plant species

Yann Joly , Katherine Huerne , Mykhailo Arych , Yvonne Bombard
Genetics 37 ( 11)

2021
Confronting New Issues in Genetic Discrimination

Yann Joly , Katherine Huerne , Mykhailo Arych , Yvonne Bombard

2021
Identifying the Key Features of an Effective Non-Discrimination Policy: A Delphi Study

Diya Uberoi , Dalpé Gratien , Katherine Cheung , Emma Kondrup

Psychosocial effects of predictive testing for Huntington disease

Michael R Hayden , Yvonne Bombard
ADVANCES IN NEUROLOGY-NEW YORK-RAVEN PRESS- 96 226 -226

26
2005
An Interaction of Genes in Our Social Environment: Genetic Discrimination Among Persons at Risk for Huntington Disease

Yvonne Bombard , Michael R Hayden
Challenging Genetic Determinism: New Perspectives on the Gene in Its Multiple Environments 182 -204

3
2011
Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective

Don Husereau , Yvonne Bombard , Tracy Stockley , Michael Carter
Current Oncology 30 ( 11) 9660 -9669

1
2023
A model for the return and referral of all clinically significant secondary findings of genomic sequencing

Rita Kodida , Emma Reble , Marc Clausen , Salma Shickh
Journal of Medical Genetics 60 ( 8) 733 -739

2
2023
Great expectations: patients’ preferences for clinically significant results from genomic sequencing

Salma Shickh , Agnes Sebastian , Marc Clausen , Chloe Mighton
Human Genetics 142 ( 4) 553 -562

1
2023